Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesImmunotherapy for tuberculosis: future prospectsPotential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisThe Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence OutcomeDoes tuberculosis threaten our ageing populations?Transformative tools for tackling tuberculosisInnate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune CellsHeterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesDuality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad copEicosanoid storm in infection and inflammationVersatile myeloid cell subsets contribute to tuberculosis-associated inflammationLow doses of imatinib induce myelopoiesis and enhance host anti-microbial immunityGranulomas and Inflammation: Host-Directed Therapies for Tuberculosis.Disease-promoting effects of type I interferons in viral, bacterial, and coinfectionsTB drug development: immunology at the tableMycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human TuberculosisIdentification of resolvin D2 receptor mediating resolution of infections and organ protectionProtection and pathology in TB: learning from the zebrafish modelNew insights into TB physiology suggest untapped therapeutic opportunitiesTuberculosis vaccines: barriers and prospects on the quest for a transformative toolDissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional modelThe human immune response to tuberculosis and its treatment: a view from the bloodxCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammationNew tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsMembrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in Tuberculosis.A blood RNA signature for tuberculosis disease risk: a prospective cohort study.Association between a history of mycobacterial infection and the risk of newly diagnosed Sjögren's syndrome: A nationwide, population-based case-control study.Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes.Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infectionBeyond macrophages: the diversity of mononuclear cells in tuberculosis.The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis.Advancing host-directed therapy for tuberculosis.Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosisSendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.Macrophage immunoregulatory pathways in tuberculosis.Cytokine and lipid mediator networks in tuberculosisA robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infectionLimited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection.Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against Tuberculosis.
P2860
Q21131160-3C370BD4-D988-4178-A823-5AA2C33B85E9Q26741261-CDB5D590-4740-4F98-BD9F-8A7D03E911E0Q26746099-54E1F126-002A-421F-BA6F-5FA16EF23454Q26751427-1DFD929C-76BA-47EA-BF34-FE9F6DC3DD7BQ26766255-3005931D-F8E4-4CC4-A10C-5315F0E9AF22Q26784084-160229C4-4341-49BA-B6F5-8C7F29E6C614Q26799901-D0CB7026-4779-4D28-94C9-B058834CF295Q26823503-15D7F8F4-20B8-4DF3-86EF-86715C89CF8DQ26823530-30A3E9CC-EFBA-4902-8204-DED6EB5EFDF6Q26851985-E865765D-AE27-4112-9C0E-84AD45295100Q26997007-81A0D5E4-22BD-47B6-9A05-4DD90BF9E7A0Q27320733-734551EE-0140-4997-9718-BEC24F47AA6CQ28076037-DCC7CD95-9871-46EF-8761-95E69AF80E9EQ28082841-2F51BD2B-CD45-4988-81F5-BC1F283AF509Q28083600-4AD1FEA8-6E03-46C0-B7B0-4F3E2FF972E7Q28083909-8FF9B077-B0D8-4D9C-BEF3-46CB855ECB9EQ28265395-B164DF6D-7DC1-4FBE-8016-44F664254605Q28266814-DD009941-659C-4B75-9FD0-957235E56E77Q28388477-64A86D02-261E-47D6-A82A-2315F038E342Q28390218-CB3442B4-3E09-4E07-B5E9-DB0270617D2BQ28468572-DB024E8A-4489-4957-A94B-AC6F48896758Q28544750-E0919522-02F6-4512-A319-4C186A11F416Q28822245-4D41FA97-FA86-497F-805F-673CEEC9F4D7Q30371980-6A6A38EF-F5AB-4C96-B466-D93A6A46B944Q30375886-D6823B5A-1A50-4885-B62C-0E45E8AE4941Q33566308-E71F423A-A914-490C-AD87-B06C4056D16BQ33652953-07991DCF-1AF1-4FF3-9DD7-228741DF371BQ33665347-F5C0499A-435C-4A9F-98DB-8E8FE07C3C75Q33758400-12CAD1B7-EEA4-44B1-9356-0FC973175627Q34372502-8E90C6CA-579F-451C-BFF2-83A38307EDF7Q34462437-0A726578-3689-4E25-AB45-41764EE6E552Q34466861-1D87E3F8-25B9-4034-856D-B047DBA9C20CQ34505943-B89559D0-D197-46E0-9C20-2C7AE1749865Q34594056-DA91605E-C1FE-4584-A392-BBF3DC33807BQ35039679-98356C71-973C-4F41-980E-7EFA99C06D88Q35117086-2B53EE43-E4B8-4CF6-8D32-3E6AB57E51F6Q35568496-6E235359-DAF3-430D-B0B9-1FF6BBC580B6Q35608012-C7C064E2-B710-49AA-ABDF-5233D0291634Q35623978-F59E129C-CFE1-4835-A481-FCFE16C8CA76Q35645947-4BBC7AB1-BC66-4C82-8DD1-B3AA817B5F94
P2860
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@ast
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@en
type
label
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@ast
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@en
prefLabel
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@ast
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@en
P2093
P2860
P50
P356
P1433
P1476
Host-directed therapy of tuber ...... d type I interferon crosstalk.
@en
P2093
Andres M Salazar
Bruno B Andrade
Daniel L Barber
Guolong Zhang
Jacqueline Gonzales
Katrin D Mayer-Barber
Marta Catalfamo
Nathella Pavan Kumar
P2860
P2888
P304
P356
10.1038/NATURE13489
P407
P577
2014-06-25T00:00:00Z
P5875
P6179
1043550399